Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

ARIFAM™ modified-release tablets 10mg+1.5mg, 30pcs

🔥 4 items sold in last 3 hours
24 people are viewing this product
Brand:

$57.5

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ARIFAM™ modified-release tablets 5mg+1.5mg, 30pcs

$55.0
Add to cart

Analogs of ARIFAM™

AMLODIPINE tablets 10mg, 120pcs

$20.0
Add to cart

AMLODIPINE tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE tablets 10mg, 60pcs

$17.5
Add to cart

AMLODIPINE tablets 10mg, 90pcs

$20.0
Add to cart

Table of Contents

ARIFAM™ 10mg+1.5mg Tablets Buy Online

ARIFAM Modified-Release Tablets: A Comprehensive Overview

Managing high blood pressure effectively is crucial for long-term cardiovascular health. ARIFAM modified-release tablets offer a combined approach to hypertension management, providing a convenient once-daily dosage regimen.

This comprehensive overview explores the key features, benefits, and potential drawbacks of ARIFAM, empowering you to make informed decisions in consultation with your healthcare provider. Understanding the mechanism of action and potential side effects is vital for safe and effective use.

ARIFAM combines two active ingredients working synergistically to lower blood pressure: amlodipine, a calcium channel blocker, and indapamide, a thiazide-like diuretic. This dual action addresses hypertension from multiple angles, potentially leading to better blood pressure control.

Understanding ARIFAM

ARIFAM is a combination antihypertensive medication designed to effectively manage high blood pressure. It achieves this through the synergistic action of two key components: amlodipine and indapamide. This unique formulation offers a convenient once-daily dosage for patients seeking consistent blood pressure control.

Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby reducing the resistance to blood flow. This leads to a decrease in blood pressure. Indapamide, a thiazide-like diuretic, helps the body eliminate excess sodium and water, further contributing to lower blood pressure levels.

The modified-release formulation of ARIFAM ensures a sustained and controlled release of both amlodipine and indapamide throughout the day. This controlled release mechanism helps maintain consistent blood pressure levels, minimizing fluctuations and potential side effects associated with immediate-release formulations. The extended release nature of the medication contributes to improved patient compliance, as it requires only a single daily dose.

Understanding the individual roles of amlodipine and indapamide within ARIFAM’s mechanism of action helps patients appreciate the comprehensive approach to blood pressure management offered by this medication. The combined effect of these two active components is designed to provide superior blood pressure control compared to using either drug alone, making it a valuable treatment option for many individuals.

Mechanism of Action

ARIFAM’s effectiveness stems from the combined action of its two active ingredients: amlodipine and indapamide. These components work synergistically to lower blood pressure through distinct yet complementary mechanisms.

Amlodipine, a calcium channel blocker, primarily targets the smooth muscles in the walls of blood vessels. By inhibiting the influx of calcium ions, amlodipine causes relaxation and dilation of these vessels. This vasodilation reduces peripheral resistance, thereby lowering blood pressure. The effect is a reduction in the workload on the heart.

Indapamide, a thiazide-like diuretic, acts by increasing the excretion of sodium and water from the body through the kidneys. This diuretic effect reduces blood volume, further contributing to the lowering of blood pressure. The combined effects of vasodilation and reduced blood volume result in a more comprehensive and often more effective blood pressure reduction compared to using either drug alone.

The modified-release formulation of ARIFAM is crucial to its mechanism of action. This controlled release ensures a sustained and even delivery of both amlodipine and indapamide throughout the day, leading to more stable blood pressure control and minimizing the potential for significant fluctuations. This sustained release profile contributes to better overall efficacy and reduced risk of adverse events.

Dosage and Administration

ARIFAM modified-release tablets are typically administered once daily, preferably in the morning. This convenient dosing schedule simplifies adherence to the prescribed treatment regimen and improves patient compliance. Consistency is crucial for effective blood pressure management.

The tablets should be swallowed whole with a glass of water; crushing or chewing the tablets is strongly discouraged. This is because the modified-release formulation is designed to provide a sustained release of the active ingredients throughout the day. Altering the tablet’s integrity could compromise this controlled release and potentially lead to unpredictable blood pressure fluctuations.

The recommended dose of ARIFAM is usually one tablet per day, but individual dosages may vary depending on the patient’s specific needs and response to treatment. A healthcare professional will determine the appropriate dosage based on factors such as the severity of hypertension, the patient’s overall health, and any potential drug interactions. Close monitoring of blood pressure and regular consultations with a doctor are important for safe and effective use.

It is essential to follow the prescribed dosage and administration instructions carefully. Any adjustments to the dosage should only be made under the guidance of a healthcare professional. Improper use may affect the efficacy of the medication and potentially increase the risk of adverse effects. Consistent adherence to the prescribed regimen is paramount for optimal therapeutic outcomes.

Potential Benefits of ARIFAM

ARIFAM offers several potential benefits for individuals managing hypertension. Its unique combination of amlodipine and indapamide provides a comprehensive approach to blood pressure control, potentially leading to improved cardiovascular health outcomes. The once-daily dosage simplifies the treatment regimen, promoting better patient adherence and ultimately, better long-term blood pressure management.

The modified-release formulation ensures a sustained release of active ingredients, leading to more stable blood pressure levels throughout the day. This helps minimize the fluctuations that can occur with immediate-release formulations, contributing to a more consistent therapeutic effect and potentially reducing the risk of adverse events. The sustained action also promotes better patient compliance due to the convenience of a single daily dose.

By combining a calcium channel blocker and a diuretic, ARIFAM addresses hypertension from two different angles. This dual mechanism of action may prove more effective than using either drug alone, potentially resulting in more significant blood pressure reduction for some individuals. The combined effect may also provide broader cardiovascular protection, benefiting various aspects of heart health.

For patients whose hypertension is not adequately controlled by monotherapy, ARIFAM offers a convenient and potentially more effective alternative. This combined therapy may lead to improved blood pressure control, resulting in a reduced risk of cardiovascular complications such as stroke, heart attack, and kidney disease. However, individual responses to medication vary, and a healthcare professional’s guidance is always crucial.

Pros

  • Convenient once-daily dosage: Simplifies treatment adherence and improves patient compliance, leading to better long-term blood pressure management. This single daily dose reduces the likelihood of missed doses and simplifies the overall treatment process for patients.
  • Combination therapy: The synergistic action of amlodipine and indapamide offers a comprehensive approach to blood pressure control, potentially resulting in more significant blood pressure reduction than monotherapy for some individuals. This combined action addresses hypertension from multiple angles.
  • Modified-release formulation: Provides sustained release of active ingredients, leading to more stable blood pressure levels throughout the day. This controlled release minimizes fluctuations and enhances the consistency of therapeutic effects.
  • Potential for improved cardiovascular health: Effective blood pressure control reduces the risk of serious cardiovascular complications such as stroke, heart attack, and kidney disease. This benefit extends beyond simple blood pressure reduction to broader cardiovascular well-being.
  • May be effective for patients unresponsive to monotherapy: ARIFAM offers a valuable alternative for those whose hypertension is not adequately managed with single-drug therapy. The dual mechanism of action may provide a more effective approach in such cases.

Potential Drawbacks of ARIFAM

While ARIFAM offers significant benefits in managing hypertension, it’s crucial to acknowledge potential drawbacks. Like all medications, ARIFAM can cause side effects, although not everyone experiences them. The severity and frequency of side effects vary considerably among individuals, and careful monitoring is essential.

Some commonly reported side effects include headache, dizziness, fatigue, and swelling in the ankles or feet. These are often mild and may subside as the body adjusts to the medication. However, if these or any other side effects persist or worsen, it is crucial to consult a healthcare professional immediately. Prompt attention to any concerning symptoms is essential for safe medication use.

More serious, though less common, side effects can include irregular heartbeat, chest pain, and allergic reactions. These necessitate immediate medical attention. Individuals with pre-existing heart conditions, liver or kidney disease, or a history of allergic reactions to similar medications should discuss the potential risks with their doctor before starting ARIFAM. A thorough medical evaluation is crucial before commencing any new medication.

It’s important to remember that this information is for general knowledge and does not replace professional medical advice. A healthcare professional can provide a comprehensive risk assessment and determine if ARIFAM is the appropriate medication for an individual’s specific needs and health status. Always prioritize consultation with a qualified physician before starting or altering any medication regimen.

Cons

  • Potential side effects: While generally well-tolerated, ARIFAM can cause side effects such as headache, dizziness, fatigue, and swelling in the extremities. These are usually mild and transient, but their occurrence necessitates careful monitoring and potential adjustments to the treatment regimen. The severity and frequency of side effects can vary significantly among individuals.
  • Risk of serious, though rare, adverse events: More serious side effects, such as irregular heartbeat, chest pain, and allergic reactions, are possible, though less frequent. These necessitate immediate medical attention and underscore the importance of regular medical check-ups while taking ARIFAM.
  • Drug interactions: ARIFAM may interact with other medications, potentially affecting their efficacy or increasing the risk of side effects. It’s crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking to minimize potential drug interactions.
  • Not suitable for everyone: ARIFAM is contraindicated in individuals with certain pre-existing conditions, such as severe kidney disease or hypersensitivity to its components. A thorough medical assessment is necessary to determine suitability.
  • Individual responses vary: The effectiveness of ARIFAM can vary among individuals. What works well for one person may not be as effective for another. Regular blood pressure monitoring and adjustments to the treatment plan as needed are therefore crucial.

Precautions and Warnings

Before starting ARIFAM, it’s vital to inform your doctor about your complete medical history, including any pre-existing conditions, allergies, and current medications. This comprehensive disclosure helps ensure the safe and effective use of ARIFAM and minimizes potential risks. Open communication with your healthcare provider is crucial for personalized medical care.

ARIFAM should be used with caution in patients with impaired liver or kidney function. Dosage adjustments may be necessary to prevent adverse effects. Regular monitoring of liver and kidney function is crucial during treatment, particularly in patients with pre-existing conditions affecting these organs. Close collaboration with your doctor ensures safe and appropriate management.

Elderly patients may be more susceptible to certain side effects of ARIFAM. Careful monitoring and potential dosage adjustments are often necessary for this population. The physician should tailor the treatment plan to the individual’s specific needs and health status, ensuring the best possible outcome while minimizing potential risks.

ARIFAM can cause dizziness or lightheadedness, particularly at the beginning of treatment. Patients should avoid driving or operating machinery until they know how the medication affects them. Caution should also be exercised when engaging in activities that require alertness or coordination. Safety is paramount, and awareness of potential side effects is essential for responsible medication use.

Who Should Use ARIFAM?

ARIFAM is primarily prescribed for adults with essential hypertension, a common condition characterized by persistently high blood pressure. It’s particularly beneficial for individuals whose blood pressure remains inadequately controlled despite treatment with a single antihypertensive medication. The combined action of amlodipine and indapamide makes ARIFAM a valuable option for those needing a more comprehensive approach to blood pressure management.

The decision to prescribe ARIFAM should be made by a healthcare professional based on a thorough assessment of the patient’s individual health status. This assessment includes considering the patient’s medical history, current medications, and potential drug interactions. A comprehensive evaluation helps determine if ARIFAM is the most appropriate and safe treatment option for a particular individual.

Patients with certain pre-existing conditions, such as severe kidney disease, may not be suitable candidates for ARIFAM. Similarly, individuals with a history of allergic reactions to amlodipine, indapamide, or other related medications should exercise caution and discuss the risks with their doctor before initiating treatment. Prioritizing patient safety and selecting the most appropriate medication is paramount.

Ultimately, the suitability of ARIFAM is determined on a case-by-case basis by a healthcare professional. Open communication between patient and doctor is essential to ensure the safe and effective use of this medication. Regular monitoring of blood pressure and overall health is also crucial for optimal therapeutic outcomes and timely adjustments to the treatment plan, if necessary.

Conclusion

ARIFAM modified-release tablets offer a potentially effective approach to managing hypertension, combining the benefits of amlodipine and indapamide in a convenient once-daily dosage. The sustained-release formulation aims to provide stable blood pressure control throughout the day, improving patient compliance and potentially reducing the risk of adverse events associated with fluctuating blood pressure.

While ARIFAM presents several advantages, including a convenient dosage and a dual mechanism of action, potential side effects and drug interactions must be carefully considered. It is crucial to remember that individual responses to medication vary, and what works well for one person may not be as effective or safe for another. Therefore, close monitoring by a healthcare professional is essential for safe and effective use.

This information serves as an overview and should not replace professional medical advice. Before starting ARIFAM or any other medication, a comprehensive consultation with a physician is paramount. This allows for a personalized assessment of your health status, potential risks, and the selection of the most appropriate treatment strategy. Open communication with your doctor is key to managing your hypertension effectively and safely.

Ultimately, the decision to use ARIFAM should be made in collaboration with your healthcare provider. They can assess your individual needs, considering your medical history, other medications, and potential risks, to determine if ARIFAM is the right choice for you. Prioritizing a collaborative approach to healthcare ensures optimal management of your hypertension and overall well-being.

  • Arifam™ Modified-Release Tablets 10Mg+1.5Mg, 30Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Arifam™ Modified-Release Tablets 10Mg+1.5Mg, 30Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Arifam™ Modified-Release Tablets 10Mg+1.5Mg, 30Pcs Buy Online 6
    [Medical reviewer]

    Dr. David J. Bronster, MD, is a distinguished Professor of Neurology and Neurological Consultant to the Recanati/Miller Transplantation Institute. With an impressive 36-year career in consultative wor...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “ARIFAM™ modified-release tablets 10mg+1.5mg, 30pcs”

Your email address will not be published. Required fields are marked

Similar products

ARIFON™ RETARD™ prolonged-release tablets 1.5mg, 30pcs

$23.0
Add to cart

APROVASK™ tablets 10mg+150mg, 28pcs

$73.5
Add to cart

APROVASK™ tablets 10mg+300mg, 28pcs

$102.5
Add to cart

APROVASK™ tablets 10mg+300mg, 56pcs

$176.0
Add to cart

APROVEL™ tablets 300mg, 28pcs

$110.5
Add to cart

ANGIAKAND™ tablets 16mg, 28pcs

$57.5
Add to cart

ANGIAKAND™ tablets 8mg, 28pcs

$52.0
Add to cart

ANAPRILIN™ RENEVAL™ tablets 40mg, 112pcs

$15.0
Add to cart

ANAPRILIN™ RENEVAL™ tablets 10mg, 112pcs

$9.5
Add to cart

AMPRILAN™ tablets 1.25mg, 30pcs

$8.0
Add to cart

AMPRILAN™ tablets 10mg, 30pcs

$17.5
Add to cart

AMPRILAN™ tablets 5mg, 30pcs

$9.5
Add to cart

AMLODIPINE+PERINDOPRIL-SZ™ tablets 10mg+8mg, 30pcs

$28.0
Add to cart

AMLODIPINE-AKOS™ tablets 10mg, 30pcs

$13.5
Add to cart

AMLODIPINE-VERTEX™ tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE-VERTEX™ tablets 5mg, 30pcs

$9.5
Add to cart

AMLODIPINE-VERTEX™ tablets 5mg, 60pcs

$11.0
Add to cart

AMLODIPINE-TEVA™ tablets 5mg, 30pcs

$16.0
Add to cart

AMLODIPINE tablets 10mg, 90pcs

$21.5
Add to cart

AMLODIPINE tablets 5mg, 90pcs

$13.5
Add to cart

AMLODIPINE+VALSARTAN tablets 10mg+160mg, 30pcs

$40.0
Add to cart

AMLODIPINE+VALSARTAN tablets 10mg+160mg, 90pcs

$73.5
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+160mg, 90pcs

$69.5
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 30pcs

$29.5
Add to cart
Select your currency